The DOI matches its Crossref record; 48 of the 51 references it cites were found in a registry or an index.
Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis: Incretins, gastric emptying and metabolic control
Open accessAbstract
BACKGROUND: Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are major incretins with important effects on glucoregulatory functions. The aim of this study was to investigate effects of GIP and GLP-1 on gastric emptying and appetite after a mixed meal, and effects on insulin secretion and glucose disposal in humans. METHODS: Randomized crossover single-blind study in 17 healthy volunteers receiving GIP (2 or 5 pmol kg(-1) min(-1), n = 8), GLP-1 (0.75 pmol kg(-1) min(-1), n = 9) or NaCl for 180 min with a radionuclide-labeled omelette and fruit punch (370 kcal). Outcome measures were gastric emptying rate, insulinogenic index, hunger, satiety, desire to eat, and prospective food consumption. Blood was analyzed for GIP, GLP-1, glucagon, C-peptide, peptide YY (PYY) and ghrelin. KEY RESULTS: Glucose-dependent insulinotropic polypeptide 2 and 5 pmol kg(-1) min(-1) decreased gastric half-emptying time from 128.5 ± 34.0 min in controls to 93.3 ± 6.3 and 85.2 ± 11.0 min (P < 0.05). Glucose-dependent insulinotropic polypeptide 5 pmol kg(-1) min(-1) decreased postprandial glucose (P < 0.001) and insulin (P < 0.05) with increased insulinogenic index. Glucose-dependent insulinotropic polypeptide had no effects on hunger, desire to eat, satiety or prospective consumption. Glucagon-like peptide-1 0.75 pmol kg(-1) min(-1) increased half-emptying time from 76.6 ± 7.6 min to 329.4 ± 71.6 (P < 0.01). Glucagon-like peptide-1 decreased plasma glucose and insulin (both P < 0.05-0.001), and increased insulinogenic index markedly. Hunger, desire to eat and prospective consumption were decreased (P < 0.05), and satiety borderline increased (P < 0.06). CONCLUSION & INFERENCES: The incretin effect of GIP and GLP-1 differs as GLP-1 exerts a strong glucoregulatory incretin through inhibition of gastric emptying, which GIP does not. Thus, GLP-1 as incretin mimetic may offer unique benefits in terms of weight loss in treatment of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GLP-1 can slow down gastric emptying through its effects on smooth muscles and the nervous system in the gastrointestinal tract.264,268”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [264]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GLP-1 suppresses glucagon secretion and has extrahepatic effects such as slowing gastric emptying and suppressing appetite signaling in the brain.16,17”
From Tirzepatide: Clinical review of the twincretin injectable (2023) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Native GIP mimicking postprandial GIP blood levels and GIPRAs did not reveal any relevant effects on GE. 3,[13][14][15]”
From The novel dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 ( GLP ‐1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long‐acting GLP ‐1 receptor agonists (2020) · cites this paper as [14]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucagon-like peptide-1 7–36: a physiological incretin in man
Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928
Buse, J. B., Henry, R. R., Han, J., Kim, D. D., Fineman, M. S., Baron, A. D., & for the Exenatide-113 Clinical Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2628 · Cited by 1,346
Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297
Self-citationNauck, M. A., Kleine, N., �rskov, C., Holst, J. J., Willms, B., & Creutzfeldt, W. (1993) · Diabetologia · doi:10.1007/bf00401145 · Cited by 1,092
Self-citationEng, J., Kleinman, W. A., Singh, L., Singh, G., & Raufman, J. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42531-8 · Cited by 1,000
Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans
Ørskov, C., Rabenhøj, L., Wettergren, A., Kofod, H., & Holst, J. J. (1994) · Diabetes · doi:10.2337/diab.43.4.535 · Cited by 916
Self-citationGutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868
Self-citationSTIMULATION OF INSULIN SECRETION BY GASTRIC INHIBITORY POLYPEPTIDE IN MAN. 1
Dupre, J., Ross, S. A., Watson, D., & Brown, J. C. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-5-826 · Cited by 860
Nauck, M. A., Niedereichholz, U., Ettler, R., Holst, J. J., Ørskov, C., Ritzel, R. A., & Schmiegel, W. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.5.e981 · Cited by 834
Self-citationTruncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man
Wettergren, A., Schjoldager, B., Mortensen, P. E., Myhre, J., Christiansen, J., & Holst, J. J. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01316798 · Cited by 670
Self-citation
Cited by
Sorted by citations
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
“264,268 Released at the gut ’ s end, GLP-1 acts on its receptors in the gastrointestinal tract, leading to reduced gastric muscle contractions and extended food retention in the stomach.”
BackgroundFurness, J. B., Rivera, L. R., Cho, H., Bravo, D. M., & Callaghan, B. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.180 · Cited by 584
Control of appetite and energy intake by SCFA: what are the potential underlying mechanisms?
Chambers, E. S., Morrison, D. J., & Frost, G. S. (2014) · Proceedings of The Nutrition Society · doi:10.1017/s0029665114001657 · Cited by 352
Relationships Between Gastric Emptying, Postprandial Glycemia, and Incretin Hormones
Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2013) · Diabetes Care · doi:10.2337/dc12-1609 · Cited by 335
Biological Function of Short-Chain Fatty Acids and Its Regulation on Intestinal Health of Poultry
Liu, L., Li, Q., Yang, Y., & Guo, A. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.736739 · Cited by 356
A high-protein diet for reducing body fat: mechanisms and possible caveats
Pesta, D. H., & Samuel, V. T. (2014) · Nutrition & Metabolism · doi:10.1186/1743-7075-11-53 · Cited by 276
“This increased gastric retention, lowered hunger and the desire to eat and augmented satiety [39].”
Seino, Y., & Yabe, D. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12065 · Cited by 255
Dimitriadis, G. D., Maratou, E., Kountouri, A., Board, M., & Lambadiari, V. (2021) · Nutrients · doi:10.3390/nu13010159 · Cited by 241
Song, X., Zhong, L., Lyu, N., Liu, F., Li, B., Hao, Y., Xue, Y., Li, J., Feng, Y., Ma, Y., et al. (2019) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2019.03.001 · Cited by 209
Gasbjerg, L. S., Helsted, M. M., Hartmann, B., Jensen, M. H., Gabe, M. B. N., Sparre-Ulrich, A. H., Veedfald, S., Stensen, S., Lanng, A. R., Bergmann, N. C., et al. (2019) · Diabetes · doi:10.2337/db18-1123 · Cited by 193
Self-citationIncretin hormones and the satiation signal
Holst, J. J. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.208 · Cited by 191
Self-citationGlucagon-like peptide 1 and appetite
Dailey, M. J., & Moran, T. H. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.11.008 · Cited by 200
The role of glucagon‐like peptide‐1 impairment in obesity and potential therapeutic implications
Madsbad, S. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12119 · Cited by 146
Urva, S., Coskun, T., Loghin, C., Cui, X., Beebe, E., O'Farrell, L., Briere, D. A., Benson, C., Nauck, M. A., & Haupt, A. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14110 · Cited by 143
Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2011) · Experimental Diabetes Research · doi:10.1155/2011/279530 · Cited by 138
Kim, D. S., Choi, H.-I., Wang, Y., Luo, Y., Hoffer, B. J., & Greig, N. H. (2017) · Cell Transplantation · doi:10.1177/0963689717721234 · Cited by 136
Wu, T., Bound, M. J., Standfield, S., Gedulin, B. R., Jones, K. L., Horowitz, M., & Rayner, C. K. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12043 · Cited by 124
Kim, Y.-K., Kim, O. Y., & Song, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01270 · Cited by 109
Nutrient-Induced Cellular Mechanisms of Gut Hormone Secretion
Lu, V. B., Gribble, F. M., & Reimann, F. M. (2021) · Nutrients · doi:10.3390/nu13030883 · Cited by 111
Eid, H. M., Wright, M. L., Kumar, N. V. A., Qawasmeh, A., Hassan, S. T. S., Mocan, A., Nabavi, S. M., Rastrelli, L., Atanasov, A. G., & Haddad, P. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00387 · Cited by 110
Halim, M. A., Degerblad, M., Sundbom, M., Karlbom, U., Holst, J. J., Webb, D., & Hellström, P. M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02006 · Cited by 107
Self-citationLipids, CHOs, proteins: Can all macronutrients put a ‘brake’ on eating?
Shin, H.-S., Ingram, J. R., McGill, A., & Poppitt, S. D. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.07.008 · Cited by 98
Relationship Between Control of Glycemia and Gastric Emptying Disturbances in Diabetes Mellitus
Halland, M., & Bharucha, A. E. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.11.021 · Cited by 85
Effects of smoking cessation on β-cell function, insulin sensitivity, body weight, and appetite
Stadler, M., Tomann, L., Storka, A., Wolzt, M., Peric, S., Bieglmayer, C., Pacini, G., Dickson, S. L., Brath, H., Bech, P., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0590 · Cited by 84
Ables, G. P., Yang, K. J. Z., Vogel, S., Hernández‐Ono, A., Yu, S., Yuen, J. J., Birtles, S., Buckett, L. K., Turnbull, A. V., Goldberg, I. J., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m029041 · Cited by 73
Recent advances in incretin‐based therapies
Russell-Jones, D. L., & Gough, S. C. L. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04483.x · Cited by 76
Schmitt, C., Portron, A., Jadidi, S., Sarkar, N., & DiMarchi, R. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13024 · Cited by 74
Artificial Sweeteners: A Systematic Review and Primer for Gastroenterologists
Spencer, M. A., Gupta, A. K., Dam, L. V., Shannon, C., Menees, S. B., & Chey, W. D. (2016) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm15206 · Cited by 69
Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective
Michałowska, J., Miller‐Kasprzak, E., & Bogdański, P. (2021) · Nutrients · doi:10.3390/nu13020351 · Cited by 77
Wirunsawanya, K., Upala, S., Jaruvongvanich, V., & Sanguankeo, A. (2017) · Journal of the American College of Nutrition · doi:10.1080/07315724.2017.1344591 · Cited by 68
Im, D. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.09.001 · Cited by 62
Dairy food products: good or bad for cardiometabolic disease?
Lovegrove, J. A., & Givens, D. I. (2016) · Nutrition Research Reviews · doi:10.1017/s0954422416000160 · Cited by 60
Gastric Sensory and Motor Functions and Energy Intake in Health and Obesity—Therapeutic Implications
Cifuentes, L., Camilleri, M., & Acosta, A. J. (2021) · Nutrients · doi:10.3390/nu13041158 · Cited by 61
Wouk, J., Dekker, R. F. H., de Queiroz, E. A. I. F., & Barbosa‐Dekker, A. M. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.02.087 · Cited by 55
How dietary amino acids and high protein diets influence insulin secretion
Yanagisawa, Y. (2023) · Physiological Reports · doi:10.14814/phy2.15577 · Cited by 52
Influences of Breast Milk Composition on Gastric Emptying in Preterm Infants
Perrella, S. L., Hepworth, A. R., Simmer, K. N., & Geddes, D. T. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000596 · Cited by 49
Altered glucose metabolism after bariatric surgery: What's GLP-1 got to do with it?
Smith, E. P., Polanco, G., Yaqub, A., & Salehi, M. (2017) · Metabolism · doi:10.1016/j.metabol.2017.10.014 · Cited by 52
The role of gut endocrine cells in control of metabolism and appetite
Parker, H. E., Gribble, F. M., & Reimann, F. M. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2014.079764 · Cited by 52
Mihai, B. M., Mihai, C., Cijevschi-Prelipcean, C., Grigorescu, E.-D., Dranga, M., Drug, V., Sporea, I., & Lăcătușu, C. M. (2018) · Journal of Diabetes Research · doi:10.1155/2018/1736959 · Cited by 46
Mima, A., Nomura, A., & Fujii, T. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115032 · Cited by 48
The effects of sitagliptin on gastric emptying in healthy humans – a randomised, controlled study
Stevens, J. E., Horowitz, M., Deacon, C. F., Nauck, M. A., Rayner, C. K., & Jones, K. L. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05198.x · Cited by 46
Zhang, Y., Li, X., Huang, G., Wang, H., Chen, H., Su, Y., Yu, K., & Zhu, W. (2022) · Animal nutrition · doi:10.1016/j.aninu.2022.06.003 · Cited by 46
Bharucha, A. E., Camilleri, M., Burton, D. D., Thieke, S. L., Feuerhak, K. J., Basu, A., & Zinsmeister, A. R. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.330 · Cited by 44
Basolo, A., Burkholder, J., Osgood, K., Graham, A. L., Bundrick, S. C., Frankl, J. A., Piaggi, P., Thearle, M. S., & Krakoff, J. A. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.017 · Cited by 46
Therapies for inter-relating diabetes and obesity – GLP-1 and obesity
Iepsen, E. W., Torekov, S. S., & Holst, J. J. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.965678 · Cited by 43
Self-citationGasbjerg, L. S., ROSENKILDE, M. M., Meier, J. J., Holst, J. J., & Knop, F. K. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15216 · Cited by 43
Self-citationPeripheral neural targets in obesity
Page, A. J., Symonds, E. L., Peiris, M., Blackshaw, L. A., & Young, R. L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01951.x · Cited by 43
The opioid effects of gluten exorphins: asymptomatic celiac disease
Pruimboom, L., & de Punder, K. (2015) · Journal of Health Population and Nutrition · doi:10.1186/s41043-015-0032-y · Cited by 43
Li, Z., Zhang, N., Wen, S., Zhang, J., Sun, X., Fan, X., & Sun, Y. (2017) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2016.12.007 · Cited by 43
Luttikhold, J., de Ruijter, F. M., van Norren, K., Diamant, M., Witkamp, R. F., van Leeuwen, P. A. M., & Vermeulen, M. A. R. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12421 · Cited by 41
Keel, P. K., Bodell, L. P., Forney, K. J., Appelbaum, J., & Williams, D. L. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.112565 · Cited by 38
Gut: A key player in the pathogenesis of type 2 diabetes?
Muscogiuri, G., Balercia, G., Barrea, L., Cignarelli, A., Giorgino, F., Holst, J. J., Laudisio, D., Orio, F., Tirabassi, G., & Colao, A. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1252712 · Cited by 37
Self-citationKapitza, C., Zdravkovic, M., Hindsberger, C., & Flint, A. (2011) · Advances in Therapy · doi:10.1007/s12325-011-0044-y · Cited by 36
Kokkorakis, M., Katsarou, A., Katsiki, N., & Mantzoros, C. S. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155689 · Cited by 35
Incretin-based therapies for obesity treatment
de Mello, A. H., Prá, M. D., Cardoso, L. C., Schraiber, R. D. B., & Rezin, G. T. (2015) · Metabolism · doi:10.1016/j.metabol.2015.05.012 · Cited by 34
Lin, Y., Chen, Y., Hsieh, H.-H., & Chen, M. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.03.015 · Cited by 33
Gastrointestinal hormones and regulation of gastric emptying
Mori, H., Verbeure, W., Schol, J., Carbone, F., & Tack, J. (2022) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000707 · Cited by 21
Gastric function in diabetic gastroparesis assessed by ultrasound and scintigraphy
Steinsvik, E. K., Sangnes, D. A., Søfteland, E. W., Biermann, M., Aßmus, J., Dimcevski, G. G., Gilja, O. H., & Hausken, T. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14235 · Cited by 34
Kabisch, S., Weickert, M. O., & Pfeiffer, A. F. H. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2141190 · Cited by 31
Metabolic variables of obese dogs with insulin resistance supplemented with yeast beta-glucan
Ferreira, C. S., Vendramini, T. H. A., Amaral, A. R., Rentas, M. F., Ernandes, M. C., da Silva, F. L., Oba, P. M., Filho, F. D. O. R., & Brunetto, M. A. (2022) · BMC Veterinary Research · doi:10.1186/s12917-021-03106-2 · Cited by 30
Kong, F., Zhao, Y., Zhang, W., Wang, X., Wu, T., Zhou, Z., Xu, Y., Xia, L., & Sun, T. (2026) · Nature Communications · doi:10.1038/s41467-025-67701-9 · Cited by 29
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Yip, J., Chiang, G. S. H., Lee, I. C. J., Lehming-Teo, R., Dai, K., Dongol, L., Wang, L. Y.-T., Teo, D. W. X., Seah, G. T., & Lehming, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010364 · Cited by 30
From endocrine to rheumatism: do gut hormones play roles in rheumatoid arthritis?
Chen, C., & Tsai, C. (2013) · Rheumatology · doi:10.1093/rheumatology/ket255 · Cited by 29
Laminarin counteracts diet-induced obesity associated with glucagon-like peptide-1 secretion
Yang, L., Wang, L., Zhu, C., Wu, J., Yuan, Y., Yu, L., Xu, Y., Xu, J., Wang, T., Liao, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19957 · Cited by 27
McIver, V. J., Mattin, L. R., Evans, G. H., & Yau, A. M. W. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0215-x · Cited by 28
Gribble, F. M., Reimann, F. M., & Roberts, G. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00002-5 · Cited by 27
Kokkinos, A. D., Tsilingiris, D., le Roux, C. W., Rubino, F., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2019.153960 · Cited by 28
Hughes, R., Horn, W. F., Wen, A., RUST, B. M., Woodhouse, L. R., Newman, J. W. I., & Keim, N. L. (2021) · Appetite · doi:10.1016/j.appet.2021.105802 · Cited by 26
GLP‐1 playing the role of a gut regulatory compound
Hellström, P. M. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02150.x · Cited by 25
Self-citationLongitudinal Changes in Fasting and Glucose-Stimulated GLP-1 and GIP in Healthy Older Subjects
Pham, H., Marathe, C. S., Phillips, L. K., Trahair, L. G., Hatzinikolas, S., Huynh, L. Q., Wu, T., Nauck, M. A., Rayner, C. K., Horowitz, M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01262 · Cited by 24
May, A. T., Crowe, M. S., Blakeney, B. A., Mahavadi, S., Wang, H., Grider, J. R., & Murthy, K. S. (2018) · Peptides · doi:10.1016/j.peptides.2018.11.007 · Cited by 25
Holst, J. J. (2021) · Diabetes · doi:10.2337/dbi21-0026 · Cited by 23
Self-citationGavrieli, A., & Mantzoros, C. S. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.3.361 · Cited by 21
Terán, I. D., Imai, K., Lacroix, I. M. E., Fogliano, V., & Udenigwe, C. C. (2019) · Journal of Food Biochemistry · doi:10.1111/jfbc.13121 · Cited by 22
Heckmann, N. D., Palmer, R. C., Mayfield, C. K., Gucev, G., Lieberman, J. R., & Hong, K. M. (2024) · Arthroplasty Today · doi:10.1016/j.artd.2024.101327 · Cited by 22
Perrella, S. L., Hepworth, A. R., Simmer, K. N., Hartmann, P. E., & Geddes, D. T. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000397 · Cited by 22
Wu, T., Rayner, C. K., & Horowitz, M. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0164 · Cited by 23
Boachie, R. T., Okoro, F. L., Imai, K., Sun, L., Elom, S. O., Nwankwo, J. O., Ejike, C. E. C. C., & Udenigwe, C. C. (2019) · Journal of Food Biochemistry · doi:10.1111/jfbc.13071 · Cited by 22
GLP-1 receptor agonists in the context of cancer: the road ahead
Miousse, I. R. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00245.2025 · Cited by 20
Mendoza-Martínez, V. M., Zavala-Solares, M. R., Espinosa-Flores, A. J., León-Barrera, K. L., Alcántara-Suárez, R., Carrillo-Ruiz, J. D., Escobedo, G., Roldán-Valadéz, E., Esquivel‐Velázquez, M., Meléndez-Mier, G., et al. (2022) · Nutrients · doi:10.3390/nu14051095 · Cited by 20
Bamba, S. (2011) · Oncology Reports · doi:10.3892/or.2011.1223 · Cited by 20
Kar, P., Cousins, C. E., Annink, C. E., Jones, K. L., Chapman, M. J., Meier, J. J., Nauck, M. A., Horowitz, M., & Deane, A. M. (2015) · Critical Care · doi:10.1186/s13054-014-0718-3 · Cited by 20
Limosilactobacillus fermentum MG4295 Improves Hyperglycemia in High-Fat Diet-Induced Mice
Kim, J. E., Lee, J. Y., & Kang, C.-H. (2022) · Foods · doi:10.3390/foods11020231 · Cited by 19
Jia, H., Wu, W., Lu, X., Zhang, J., He, C., & Zhang, H. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx112 · Cited by 19
Proglucagon-derived peptides: human physiology and therapeutic potential
Gasbjerg, L. S., Nielsen, C. K., Suppli, M. P., Grøndahl, M. F. G., Holst, J. J., Knop, F. K., Jeppesen, P. B., & Lund, A. (2025) · Physiological Reviews · doi:10.1152/physrev.00057.2024 · Cited by 19
Self-citationVedtofte, L., Knop, F. K., & Vilsbøll, T. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1288715 · Cited by 17
The Second Meal Effect and Its Influence on Glycemia
Fletcher, J. A. (2012) · Journal of Nutritional Disorders & Therapy · doi:10.4172/2161-0509.1000108 · Cited by 17
Sheng, K., Zhang, H., Yue, J., Gu, W., Gu, C., Zhang, H., & Wu, W. (2018) · Toxicology · doi:10.1016/j.tox.2018.04.007 · Cited by 17
Acute Effects of Nutritive and Non-Nutritive Sweeteners on Postprandial Blood Pressure
Pham, H., Phillips, L. K., & Jones, K. L. (2019) · Nutrients · doi:10.3390/nu11081717 · Cited by 16
Ginés, I., Gil‐Cardoso, K., D’Addario, C., Falconi, A., Bellia, F., Blay, M., Terra, X., Ardèvol, A., Pinent, M., & Beltrán‐Debón, R. (2019) · Biomolecules · doi:10.3390/biom9120865 · Cited by 16
Obesity Drug Update: The Lost Decade?
Yao, F., & MacKenzie, R. G. (2010) · Pharmaceuticals · doi:10.3390/ph3123494 · Cited by 16
Novel insights into the effects of diabetes on gastric motility
Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1129898 · Cited by 16
Gastrointestinal factors regulating lipid droplet formation in the intestine
Auclair, N., Melbouci, L., St-Pierre, D., & Levy, E. H. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.12.031 · Cited by 16
Yau, A. M. W., McLaughlin, J. T., Maughan, R. J., Gilmore, W., & Evans, G. H. (2017) · Nutrients · doi:10.3390/nu9030258 · Cited by 15
Effect of extracorporeal low‐energy shock wave on diabetic gastroparesis in a rat model
Wu, K., Chiu, Y., Yao, C., Tsai, C., Hu, M., Kuo, C., Tai, W., Chuah, S., & Hsiao, C. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14368 · Cited by 15
Hamad, S., Tari, N. R., Mathiyalagan, G., & Wright, A. J. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab116 · Cited by 14
Ancu, O., Mickute, M., Guess, N. D., Hurren, N. M., Burd, N. A., & Mackenzie, R. W. (2020) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2020-0396 · Cited by 20
Chen, Y., He, M., Lei, M. M. L., Ko, W. K. W., Lin, C., Bian, Z., & Wong, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.681648 · Cited by 14
Hellström, P. M. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00012-6 · Cited by 14
Self-citationTirzepatide: Clinical review of the twincretin injectable
Krauss, Z., Hintz, A., & Fisk, R. (2023) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxad080 · Cited by 12
Metadata
- Authors
- Edholm, T., Degerblad, M., Grybäck, P., Hilsted, L., Holst, J. J., Jacobsson, H., Efendic, S., Schmidt, P. T., & Hellström, P. M.
- Affiliations
- Karolinska Institutet (SE)
- Rigshospitalet (DK)
- University of Copenhagen (DK)
- Uppsala University (SE)
- Corresponding author
- Hellström, P. M.
- Venue
- Neurogastroenterology & Motility
- Publisher
- Wiley
- Published
- 2010-06-24
- Volume
- 22
- Issue
- 11
- Pages
- 1191-e315
- ISSN
- 1350-1925 (ISSN-L)
- OpenAlex
- W1589619385
- Cited by
- 164
- References
- 51
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 6 · 2023: 7 · 2022: 7 · 2021: 15 · 2020: 5 · 2019: 16 · 2018: 13 · 2017: 13 · 2016: 9 · 2015: 7 · 2014: 9 · 2013: 12 · 2012: 10
- FWCI
- 7.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurogastroenterology & Motility (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Stockholms Läns Landsting
- Vetenskapsrådet
- Uppsala Universitet
- Landstinget i Uppsala län
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- glucagon-like peptide-1, incretins, gastric emptying, appetite, insulin secretion, glucose homeostasis, postprandial blood glucose, insulinogenic index, satiety, hunger, mixed meal, peptide YY, ghrelin, glucagon, C-peptide, food intake regulation
- MeSH terms
- Adult, Appetite, Blood Glucose, C-Peptide, Double-Blind Method, Female, Gastric Emptying, Gastric Inhibitory Polypeptide, Glucagon, Homeostasis, Humans, Hunger, Immunoassay, Insulin, Male, Satiety Response, Cross-Over Studies, Peptide YY, Glucagon-Like Peptide 1, Ghrelin, Incretins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
